The CCBR (Center of Clinical and Basics Research) was created by one of the most renowed name in the osteoporosis scientific field, Dr. Claus Cristiansen, aiming to achieve high quality clinical research. Dr. Cristiansen invited renowned doctors in osteoporosis field worldwide to join this group. Later CCBR merged with Synarc, the company that made accessorial imaging in clinical research. Thus, CCBR has become one of the largest global networks of research and development, specialized in fast and effective subject recruitment, and in the design and conduct of clinical research. In Rio de Janeiro, Brazil, Dr. Luis Russo and Dr. Luiz Gregory established its research center, characterized by experience in conducting multicentric clinical trials, qualified staff, ethical behavior, suitable facilities, good equipment with calibration control, sophisticated data collection, fast contracts turnaround and regulatory approval, fast and effective subjects recruitment, excellent compliance with high subject retention rate, consistent data acquired with quality control. Data quality was confirmed by several international audits, including the EMEA, and ANVISA (Brazil). CCBR is recognized today as a standard for high quality research worldwide.
The concept idea of CCBR is that subject can perform all the exams and test in the same location in the same day. In a three floor building there are suitable exams rooms, laboratory (to collect and prepare blood samples), electrocardiogram, densitometry scans, mammography and X-ray equipment. The regulatory and recruitment departments make possible to recruit subjects fast and in an effective manner, and the quality department maintain the retention and data quality. With success in the field of osteoporosis, Dr. Russo and Dr. Gregory expanded to almost all outpatient areas: allergy, cardiovascular and metabolic (diabetes mellitus, hypertension, atrial fibrillation, heart failure, hypercholesterolemia, obesity, metabolic syndrome), pain, neurological (Alzheimer), pnemologia (Asthma, COPD), rheumatology (arthritis, rheumatoid arthritis), women's health, and vaccines.
Investigators in this center
Luiz De Gregorio
Luis Tavares Russo
Ana Cauceglia Melazzi
Diseases in this center
Adult Cognitive Disorder
Ischemic Heart Disease
Trials in this area
- A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease (Hoffmann-La Roche; NCT01018173; Year 2010)
- A Study of RoActemra/Actemra (Tocilizumab) Given Subcutaneously in Combination With Traditional DMARDs in Patients With Moderate to Severe Active Rheumatoid Arthritis (Hoffmann-La Roche; NCT01232569; Year 2011)